TAZ Polyclonal Antibody | G-AB-09203

TAZ Polyclonal Antibody | G-AB-09203 | Gentaur Antibodies

Overview: TAZ, also referred as WWTR1, is a transcriptional co-activator with a PDZ-binding motif that is regulated by its interaction with 14-3-3 protein. TAZ is expressed in many primary tumors, such as breast cancer, thyroid carcinoma, colorectal cancer, and glioma. TAZ has been reported to be one of the nuclear effectors of Hippo-related pathways that regulate organ size control, cancer stem cell (CSC) properties, and epithelial–mesenchymal transition (EMT) . TAZ has been defined for its role in the nucleus, where it functions directly as a transcriptional regulator by interacting with several nuclear factors as Runx2/Cbfa1, NHERF-2, TEF-1, TBX5, PAX3, PAX8 and TTF-1.

Category Type: Polyclonal Antibody

Research Areas: Cancer, Epigenetics and Nuclear Signaling, Stem Cells

Synonyms: BTK, AGMX1, AT, ATK, BPK, IMD1, PSCTK1, XLA, Bruton tyrosine kinase, TAZ, WWTR1

Reactivity: Human, Mouse

Host: Rabbit

Isotype: IgG

Gene ID: 25937

Accession #:

Clonality:

Immunogen: A synthetic peptide of human TAZ (NP_056287.1) .

Clone #:

Conjugation: Unconjugated

Swissprot: Q9GZV5

Santa Cruz:

Calculated MW:

Observed MW:

Concentration: 1 mg/mL

Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3

Purification method: Affinity purification

Application: IF

Dilution: IF 1:50-1:200

Storage: Store at -20°C. Avoid freeze / thaw cycles.

TAZ Polyclonal Antibody DataSheet